Dodge & Cox Gilead Sciences, Inc. Transaction History

Dodge & Cox

$166 Billion
Q2 2025

A detailed history of Dodge & Cox transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Dodge & Cox holds 30,818,322 shares of GILD stock, worth $3.7 Billion. This represents 2.06% of its overall portfolio holdings.

Number of Shares

30,818,322

Previous 32,694,791 5.74%

Holding current value

$3.7 Billion

Previous $3.66 Billion 6.73%

% of portfolio

2.06%

Previous 2.24%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$96.91 - $113.0 $182 Million - $212 Million	-1,876,469 Reduced 5.74%	30,818,322 $3.42 Billion
Q1 2025 May 14, 2025	SELL	$89.14 - $117.41 $22.5 Million - $29.7 Million	-252,926 Reduced 0.77%	32,694,791 $3.66 Billion
Q4 2024 Feb 13, 2025	SELL	$83.95 - $97.9 $8.23 Million - $9.6 Million	-98,020 Reduced 0.3%	32,947,717 $3.04 Billion
Q3 2024 Nov 13, 2024	SELL	$66.59 - $83.99 $5.1 Million - $6.43 Million	-76,600 Reduced 0.23%	33,045,737 $2.77 Billion
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $2.85 Million - $3.29 Million	-45,150 Reduced 0.14%	33,122,337 $2.27 Billion
Q1 2024 May 14, 2024	SELL	$71.58 - $87.29 $9.13 Million - $11.1 Million	-127,536 Reduced 0.38%	33,167,487 $2.43 Billion
Q4 2023 Feb 15, 2024	SELL	$73.27 - $83.09 $17.5 Million - $19.8 Million	-238,715 Reduced 0.71%	33,295,023 $2.7 Billion
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $33 Million - $36 Million	-446,019 Reduced 1.31%	33,533,738 $2.51 Billion
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $54.9 Million - $62.6 Million	-722,005 Reduced 2.08%	33,979,757 $2.62 Billion
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $91.5 Million - $104 Million	-1,183,390 Reduced 3.3%	34,701,762 $2.88 Billion
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $30.2 Million - $43.3 Million	-484,100 Reduced 1.33%	35,885,152 $3.08 Billion
Q3 2022 Nov 10, 2022	SELL	$59.54 - $68.01 $35.6 Million - $40.6 Million	-597,375 Reduced 1.62%	36,369,252 $2.24 Billion
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $3.46 Million - $3.9 Million	-60,003 Reduced 0.16%	36,966,627 $2.28 Billion
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $8.58 Million - $10.8 Million	-148,147 Reduced 0.4%	37,026,630 $2.2 Billion
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $5.96 Million - $6.77 Million	-91,915 Reduced 0.25%	37,174,777 $2.7 Billion
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $562 Million - $607 Million	8,304,848 Added 28.68%	37,266,692 $2.6 Billion
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $666 Million - $728 Million	10,499,694 Added 56.87%	28,961,844 $1.99 Billion
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $81.3 Million - $92.7 Million	1,354,262 Added 7.92%	18,462,150 $1.19 Billion
Q4 2020 Feb 11, 2021	BUY	$56.65 - $64.55 $255 Million - $290 Million	4,500,035 Added 35.69%	17,107,888 $997 Million
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $952,676 - $1.2 Million	15,341 Added 0.12%	12,607,853 $797 Million
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $182 Million - $212 Million	-2,518,449 Reduced 16.67%	12,592,512 $969 Million
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $147 Million - $188 Million	-2,341,312 Reduced 13.42%	15,110,961 $1.13 Billion
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $970,638 - $1.07 Million	15,752 Added 0.09%	17,452,273 $1.13 Billion
Q3 2019 Nov 13, 2019	BUY	$62.51 - $69.0 $13.1 Million - $14.5 Million	209,710 Added 1.22%	17,436,521 $1.11 Billion
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $9.47 Million - $10.6 Million	153,131 Added 0.9%	17,226,811 $1.16 Billion
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $34.6 Million - $38.8 Million	553,250 Added 3.35%	17,073,680 $1.11 Billion
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $4.25 Million - $5.55 Million	70,249 Added 0.43%	16,520,430 $1.03 Billion
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $13.6 Million - $15 Million	190,370 Added 1.17%	16,450,181 $1.27 Billion
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $52.8 Million - $61.6 Million	814,350 Added 5.27%	16,259,811 $1.15 Billion
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $2.12 Million - $2.58 Million	29,100 Added 0.19%	15,445,461 $1.16 Billion
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $392 Million - $460 Million	5,506,630 Added 55.57%	15,416,361 $1.1 Billion
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $715 Million - $847 Million	9,909,731	9,909,731 $803 Million

Others Institutions Holding GILD

# of Institutions

2,321

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.14M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $150B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dodge & Cox, based on Form 13F filings with the SEC.

News

Stay updated on Dodge & Cox with notifications on news.

Account